Collaboration is a constant theme for biotech companies, from inception to exit: researchers work together to generate novel ideas, young companies work with development and formulation partners, and collaborations between pharmaceutical companies and biotechs are the classic final phase of drug development. 

That’s just the tip of the iceberg:

Foundations work together: foundations formed by the families of patients can be the most ardent advocates for getting drugs to market, but that is an expensive process. One solution is for multiple foundations to pitch in to fund the same project. That was the story with CureDuchenne and the Foundation . . . [more]

One aspect of the Olympic Movement I had never heard of before is the Olympic Truce. The concept was started in Ancient Greece, when countries would call a truce to allow athletes to travel in peace to the Olympic games and back. The concept was re-instituted by the International Olympic Committee (IOC) in 1992 as a platform of peace. The IOC launched the International Olympic Truce Foundation and the International Olympic Truce Centre in July 2000. From the olympictruce.org website with regard to supporting this ideal:

The Olympic Truce call

At the dawn of the 21st century, the Olympic Truce